---
title: "Sinocelltech: Lan Zhanghua resigns from the position of Deputy General Manager of the company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233839364.md"
description: "On March 31, Sinocelltech announced that the company recently received a written resignation letter from Vice President Lan Zhanghua. Lan Zhanghua resigned from the position of Vice President of the company and its holding subsidiary Sinocelltech Engineering Co., Ltd. due to retirement application. After resignation, he will no longer hold any position in the company or its holding subsidiary. The resignation letter will take effect from the date it is delivered to the board of directors"
datetime: "2025-03-31T08:07:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233839364.md)
  - [en](https://longbridge.com/en/news/233839364.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233839364.md)
generator: "portal-rs"
---

# Sinocelltech: Lan Zhanghua resigns from the position of Deputy General Manager of the company

Sinocelltech announced on March 31 that the company recently received a written resignation letter from Vice President Lan Zhanghua. Lan Zhanghua resigned from the position of Vice President of the company and its holding subsidiary Sinocelltech Engineering Co., Ltd. due to retirement application, and will no longer hold any position in the company or its holding subsidiary after resignation. The resignation letter will take effect from the date it is delivered to the board of directors

### Related Stocks

- [688520.CN](https://longbridge.com/en/quote/688520.CN.md)

## Related News & Research

- [Revolut wins US charter with limits on four products](https://longbridge.com/en/news/297960478.md)
- [08:27 ETHyGen Promotes Omid Ghobadi to Chief Operating Officer](https://longbridge.com/en/news/297786116.md)
- [China Internet Investment Fund targets deep-sea, low-altitude embodied intelligence applications, chair says](https://longbridge.com/en/news/298032703.md)
- [Is U.S. Physical Therapy (USPH) Still Below Fair Value After Its Midwest IDEAS Appearance?](https://longbridge.com/en/news/298039851.md)
- [Knight Therapeutics wins Colombia approval for Tavalisse in chronic ITP](https://longbridge.com/en/news/297703037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**